Pyrrolopyrazine derivatives: synthetic approaches and biological activities

被引:0
作者
Fateme Dehnavi
Seyedeh Roya Alizadeh
Mohammad Ali Ebrahimzadeh
机构
[1] Mazandaran University of Medical Sciences,Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences Research Center
来源
Medicinal Chemistry Research | 2021年 / 30卷
关键词
Pyrrolopyrazine; Synthetic methods; Drug discovery; Antimicrobial activity; Anti; inflammatory; Antitumor activity;
D O I
暂无
中图分类号
学科分类号
摘要
Nitrogen-containing heterocycles were employed in different applications such as pharmaceuticals, organic materials, natural products, and mainly in bioactive molecules. Pyrrolopyrazine as a biologically active scaffold contains pyrrole and pyrazine rings. Compounds with this scaffold have widely exhibited different biological activities, such as antimicrobial, anti-inflammatory, antiviral, antifungal, antioxidant, antitumor, and kinase inhibitory. In addition, many pyrrolopyrazine derivatives have been isolated from plants, microbes, soil, marine life, and other sources. This review explained various synthetic routes for pyrrolopyrazine derivatives, including cyclization, ring annulation, cycloaddition, direct C-H arylation, and other methods. Besides, pyrrolopyrazines are classified into three chemical categories with two or three nitrogen atoms, indicating various biological activities. According to the findings, pyrrolo [1,2-a] pyrazine derivatives exhibited more antibacterial, antifungal, and antiviral activities, while 5H-pyrrolo [2,3-b] pyrazine derivatives showed more activity on kinase inhibition. However, studies show that the action mechanisms of pyrrolopyrazine derivatives are not clearly recognized. Moreover, despite the scaffold’s importance, there are only a few Structure-Activity Relationship (SAR) research on it. Therefore, the synthetic methods and biological activities of pyrrolopyrazine derivatives discussed in this paper will certainly help medicinal chemistry researchers design and synthesize new leads to treat various diseases.
引用
收藏
页码:1981 / 2006
页数:25
相关论文
共 478 条
[1]  
Vitaku E(2014)Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among us FDA approved pharmaceuticals: miniperspective J Med Chem 57 10257-74
[2]  
Smith DT(2013)Unequivocal role of pyrazine ring in medicinally important compounds: a review Mini Rev Med Chem 13 1607-25
[3]  
Njardarson JT(1991)Synthesis and properties of pyrrolo [1, 2- Chem Heterocycl Compd 27 1037-48
[4]  
Miniyar PB(1998)] pyrazines Expert Opin Ther Pat 8 383-93
[5]  
Murumkar PR(1996)Selective dopamine D4 receptor antagonists Biochem Biophys Res Commun 221 548-53
[6]  
Patil PS(2015)Inhibition of human immunodeficiency virus type 1 long terminal repeat-driven transcription by anin vivometabolite of oltipraz: implications for antiretroviral therapy Bioorg Med Chem Lett 25 5384-8
[7]  
Barmade MA(2016)Identification of N-(1H-pyrazol-4-yl) carboxamide inhibitors of interleukin-1 receptor associated kinase 4: bicyclic core modifications Am J Plant Sci 7 1077-85
[8]  
Bothara KG(2015)Bioactive compounds produced by Streptomyces sp. isolate UPMRS4 and antifungal activity against Pyricularia oryzae Bioorg Med Chem 23 3368-78
[9]  
Terenin V(2015)Design, synthesis and anxiolytic-like activity of 1-arylpyrrolo [1, 2- Future Med Ltd 7 437-48
[10]  
Kabanova E(2015)] pyrazine-3-carboxamides Eur J Med Chem. 99 1-13